AAAAAA

   
Results: 1-25 | 26-50
Results: 1-25/50
COMBINATION OF IRINOTECAN AND ETOPOSIDE FOR TREATMENT OF REFRACTORY OR RELAPSED SMALL-CELL LUNG-CANCER
Authors: MASUDA N MATSUI K NEGORO S TAKIFUJI N TAKEDA K YANA T KOBAYASHI M HIRASHIMA T KUSUNOKI Y USHIJIMA S KAWASE I TADA T SAWAGUCHI H FUKUOKA M
Citation: N. Masuda et al., COMBINATION OF IRINOTECAN AND ETOPOSIDE FOR TREATMENT OF REFRACTORY OR RELAPSED SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 16(10), 1998, pp. 3329-3334
ONTOLOGICAL MEASUREMENT
Authors: GUNJI YP ITO K KUSUNOKI Y
Citation: Yp. Gunji et al., ONTOLOGICAL MEASUREMENT, Biosystems, 46(1-2), 1998, pp. 175-183
CHARACTERISTIC CHANGES OF LARGE GRANULAR LYMPHOCYTES THAT STRONGLY EXPRESS CD56 IN ENDOMETRIUM DURING THE MENSTRUAL-CYCLE AND EARLY-PREGNANCY
Authors: KODAMA T HARA T OKAMOTO E KUSUNOKI Y OHAMA K
Citation: T. Kodama et al., CHARACTERISTIC CHANGES OF LARGE GRANULAR LYMPHOCYTES THAT STRONGLY EXPRESS CD56 IN ENDOMETRIUM DURING THE MENSTRUAL-CYCLE AND EARLY-PREGNANCY, Human reproduction (Oxford. Print), 13(4), 1998, pp. 1036-1043
LIFE-SPAN OF HUMAN-MEMORY T-CELLS IN THE ABSENCE OF T-CELL RECEPTOR EXPRESSION
Authors: UMEKI S KUSUNOKI Y COLOGNE JB IWAMOTO KS HIRAI Y SEYAMA T OHAMA K KYOIZUMI S
Citation: S. Umeki et al., LIFE-SPAN OF HUMAN-MEMORY T-CELLS IN THE ABSENCE OF T-CELL RECEPTOR EXPRESSION, Immunology letters, 62(2), 1998, pp. 99-104
FLOW-CYTOMETRY MEASUREMENTS OF SUBSETS OF T-CELL, B-CELL AND NK CELL IN PERIPHERAL-BLOOD LYMPHOCYTES OF ATOMIC-BOMB SURVIVORS
Authors: KUSUNOKI Y KYOIZUMI S HIRAI Y SUZUKI T NAKASHIMA E KODAMA K SEYAMA T
Citation: Y. Kusunoki et al., FLOW-CYTOMETRY MEASUREMENTS OF SUBSETS OF T-CELL, B-CELL AND NK CELL IN PERIPHERAL-BLOOD LYMPHOCYTES OF ATOMIC-BOMB SURVIVORS, Radiation research, 150(2), 1998, pp. 227-236
GABEXATE MESILATE PLUS INTRAVENOUS GAMMA-GLOBULIN TREATMENT IN CHILDREN WITH DIARRHEA-ASSOCIATED HEMOLYTIC-UREMIC SYNDROME
Authors: KUSUNOKI Y NOBUMOTO K OHKAWA M WATANABE T HAMADA I TOCHIMARU H
Citation: Y. Kusunoki et al., GABEXATE MESILATE PLUS INTRAVENOUS GAMMA-GLOBULIN TREATMENT IN CHILDREN WITH DIARRHEA-ASSOCIATED HEMOLYTIC-UREMIC SYNDROME, Nephron, 79(2), 1998, pp. 227-228
T-CELLS SPECIFIC FOR A POLYMORPHIC SEGMENT OF CD45 INDUCE GRAFT-VERSUS-HOST DISEASE WITH PREDOMINANT PULMONARY VASCULITIS
Authors: CHEN W CHATTA GS RUBIN WD CLARK JG HACKMAN RC MADTES DK LIGITT DH KUSUNOKI Y MARTIN PJ CHEEVER MA
Citation: W. Chen et al., T-CELLS SPECIFIC FOR A POLYMORPHIC SEGMENT OF CD45 INDUCE GRAFT-VERSUS-HOST DISEASE WITH PREDOMINANT PULMONARY VASCULITIS, The Journal of immunology (1950), 161(2), 1998, pp. 909-918
PREVENTION OF MARROW GRAFT-REJECTION WITHOUT INDUCTION OF GRAFT-VERSUS-HOST DISEASE BY A CYTOTOXIC T-CELL CLONE THAT RECOGNIZES RECIPIENT ALLOANTIGENS
Authors: KUSUNOKI Y CHEN W MARTIN PJ
Citation: Y. Kusunoki et al., PREVENTION OF MARROW GRAFT-REJECTION WITHOUT INDUCTION OF GRAFT-VERSUS-HOST DISEASE BY A CYTOTOXIC T-CELL CLONE THAT RECOGNIZES RECIPIENT ALLOANTIGENS, Blood, 91(11), 1998, pp. 4038-4044
DEVELOPMENT OF A MOUSE MODEL FOR STUDYING IN-VIVO T-CELL RECEPTOR MUTATIONS
Authors: UMEKI S SUZUKI T KUSUNOKI Y SEYAMA T FUJITA S KYOIZUMI S
Citation: S. Umeki et al., DEVELOPMENT OF A MOUSE MODEL FOR STUDYING IN-VIVO T-CELL RECEPTOR MUTATIONS, Mutation research. Genetic toxicology and environmental mutagenesis, 393(1-2), 1997, pp. 37-46
A MODEL OF INCOMPLETE IDENTIFICATION ILLUSTRATING SCHOOLING BEHAVIOR
Authors: GUNJI YP KUSUNOKI Y
Citation: Yp. Gunji et Y. Kusunoki, A MODEL OF INCOMPLETE IDENTIFICATION ILLUSTRATING SCHOOLING BEHAVIOR, Chaos, solitons and fractals, 8(10), 1997, pp. 1623-1630
CISPLATIN-BASED COMBINATION CHEMOTHERAPY FOR ELDERLY PATIENTS WITH NON-SMALL-CELL LUNG-CANCER
Authors: KUBOTA K FURUSE K KAWAHARA M KODAMA N OGAWARA M TAKADA M MASUDA N NEGORO S MATSUI K TAKIFUJI N KUDOH S KUSUNOKI Y FUKUOKA M
Citation: K. Kubota et al., CISPLATIN-BASED COMBINATION CHEMOTHERAPY FOR ELDERLY PATIENTS WITH NON-SMALL-CELL LUNG-CANCER, Cancer chemotherapy and pharmacology, 40(6), 1997, pp. 469-474
TRANSCUTANEOUS NEEDLE-BIOPSY OF THE LUNG
Authors: KOMIYA T KUSUNOKI Y KOBAYASKI M HIRASHIMA T YANA T MASUDA N MATSUI K TAKADA M NAKAGAWA K KOTAKE Y YASUMITSU T KIKUI M KAWASE I
Citation: T. Komiya et al., TRANSCUTANEOUS NEEDLE-BIOPSY OF THE LUNG, Acta radiologica, 38(5), 1997, pp. 821-825
FORMAL MODEL OF INTERNAL MEASUREMENT - ALTERNATE CHANGING BETWEEN RECURSIVE DEFINITION AND DOMAIN EQUATION
Authors: GUNJI YP ITO K KUSUNOKI Y
Citation: Yp. Gunji et al., FORMAL MODEL OF INTERNAL MEASUREMENT - ALTERNATE CHANGING BETWEEN RECURSIVE DEFINITION AND DOMAIN EQUATION, Physica. D, 110(3-4), 1997, pp. 289-312
SERIAL IMAGING IN MELAS
Authors: MIYAMOTO A OKI J TAKAHASHI S ITOH J KUSUNOKI Y CHO K
Citation: A. Miyamoto et al., SERIAL IMAGING IN MELAS, Neuroradiology, 39(6), 1997, pp. 427-430
6 SECOIRIDOID GLUCOSIDES FROM JASMINUM-POLYANTHUM
Authors: TANAHASHI T TAKENAKA Y AKIMOTO M OKUDA A KUSUNOKI Y SUEKAWA C NAGAKURA N
Citation: T. Tanahashi et al., 6 SECOIRIDOID GLUCOSIDES FROM JASMINUM-POLYANTHUM, Chemical and Pharmaceutical Bulletin, 45(2), 1997, pp. 367-372
CODE CHEMOTHERAPY WITH AND WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR IN SMALL-CELL LUNG-CANCER
Authors: FUKUOKA M MASUDA N NEGORO S MATSUI K YANA T KUDOH S KUSUNOKI Y TAKADA M KAWAHARA M OGAWARA N KODAMA N KUBOTA K FURUSE K
Citation: M. Fukuoka et al., CODE CHEMOTHERAPY WITH AND WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR IN SMALL-CELL LUNG-CANCER, British Journal of Cancer, 75(2), 1997, pp. 306-309
INTRAVENOUS GABEXATE MESILATE (IVGM) PLUS GAMMA-GLOBULIN (IVIG) TREATMENT IN CHILDHOOD HEMOLYTIC-UREMIC SYNDROME (HUS)
Authors: KUSUNOKI Y OKAWA M NOBUMOTO K WATANABE T HAMADA I TOCHIMARU H
Citation: Y. Kusunoki et al., INTRAVENOUS GABEXATE MESILATE (IVGM) PLUS GAMMA-GLOBULIN (IVIG) TREATMENT IN CHILDHOOD HEMOLYTIC-UREMIC SYNDROME (HUS), Journal of the American Society of Nephrology, 7(9), 1996, pp. 650-650
IDENTIFICATION AND IMMUNOHISTOLOGICAL LOCALIZATION OF MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF) IN HUMAN KIDNEY
Authors: IMAMURA K YASUDA K SASAKI S KUSUNOKI Y TOCHIMARU H NISHIHIRA J
Citation: K. Imamura et al., IDENTIFICATION AND IMMUNOHISTOLOGICAL LOCALIZATION OF MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF) IN HUMAN KIDNEY, Journal of the American Society of Nephrology, 7(9), 1996, pp. 2286-2286
IDENTIFICATION AND IMMUNOHISTOCHEMICAL LOCALIZATION OF MACROPHAGE-MIGRATION INHIBITORY FACTOR IN HUMAN KIDNEY
Authors: IMAMURA K NISHIHIRA J SUZUKI M YASUDA K SASAKI S KUSUNOKI Y TOCHIMARU H TAKEKOSHI Y
Citation: K. Imamura et al., IDENTIFICATION AND IMMUNOHISTOCHEMICAL LOCALIZATION OF MACROPHAGE-MIGRATION INHIBITORY FACTOR IN HUMAN KIDNEY, Biochemistry and molecular biology international, 40(6), 1996, pp. 1233-1242
DETERMINANTS OF MYELOSUPPRESSION IN THE TREATMENT OF NONSMALL CELL LUNG-CANCER WITH CISPLATIN-CONTAINING CHEMOTHERAPY
Authors: MATSUI K MASUDA N UCHIDA Y FUKUOKA M NEGORO S YANA T KUSUNOKI Y KUDOH S KAWASE I KAWAHARA M OGAWARA M KODAMA N KUBOTA K FURUSE K
Citation: K. Matsui et al., DETERMINANTS OF MYELOSUPPRESSION IN THE TREATMENT OF NONSMALL CELL LUNG-CANCER WITH CISPLATIN-CONTAINING CHEMOTHERAPY, Japanese journal of cancer research, 87(7), 1996, pp. 781-786
DOSE-ESCALATION STUDY OF ORAL ETOPOSIDE AND CARBOPLATIN IN PATIENTS WITH ADVANCED LUNG-CANCER
Authors: ATAGI S FURUSE K KAWAHARA M KODAMA N OGAWARA M KUBOTA K MATSUI K KUSUNOKI Y MASUDA N TAKADA M NEGORO S FUKUOKA M
Citation: S. Atagi et al., DOSE-ESCALATION STUDY OF ORAL ETOPOSIDE AND CARBOPLATIN IN PATIENTS WITH ADVANCED LUNG-CANCER, Japanese Journal of Clinical Oncology, 26(5), 1996, pp. 316-321
PHOTODYNAMIC THERAPY OF 168 EARLY-STAGE CANCERS OF THE LUNG AND ESOPHAGUS - A JAPANESE MULTICENTER STUDY
Authors: HAYATA Y KATO H FURUSE K KUSUNOKI Y SUZUKI S MIMURA S
Citation: Y. Hayata et al., PHOTODYNAMIC THERAPY OF 168 EARLY-STAGE CANCERS OF THE LUNG AND ESOPHAGUS - A JAPANESE MULTICENTER STUDY, Lasers in medical science, 11(4), 1996, pp. 255-259
SOMATIC-CELL MUTATIONS AT THE GLYCOPHORIN A LOCUS IN ERYTHROCYTES OF ATOMIC-BOMB SURVIVORS - IMPLICATIONS FOR RADIATION CARCINOGENESIS
Authors: KYOIZUMI S AKIYAMA M COLOGNE JB TANABE K NAKAMURA N AWA AA HIRAI Y KUSUNOKI Y UMEKI S
Citation: S. Kyoizumi et al., SOMATIC-CELL MUTATIONS AT THE GLYCOPHORIN A LOCUS IN ERYTHROCYTES OF ATOMIC-BOMB SURVIVORS - IMPLICATIONS FOR RADIATION CARCINOGENESIS, Radiation research, 146(1), 1996, pp. 43-52
RANDOMIZED TRIAL FOR THE PREVENTION OF DELAYED EMESIS IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN
Authors: MATSUI K FUKUOKA M TAKADA M KUSUNOKI Y YANA T TAMURA K YOSHIDA T IIDA K HIRASHIMA T TSUKADA H USHIJIMA S MIYAWAKI H MASUDA N
Citation: K. Matsui et al., RANDOMIZED TRIAL FOR THE PREVENTION OF DELAYED EMESIS IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN, British Journal of Cancer, 73(2), 1996, pp. 217-221
PRO-GASTRIN-RELEASING PEPTIDE(31-98) AS A TUMOR-MARKER OF SMALL-CELL LUNG-CANCER - COMPARATIVE-EVALUATION WITH NEURON-SPECIFIC ENOLASE
Authors: TAKADA M KUSUNOKI Y MASUDA N MATUI K YANA T USHIJIMA S IIDA K TAMURA K KOMIYA T KAWASE I KIKUI N MORINO H FUKUOKA M
Citation: M. Takada et al., PRO-GASTRIN-RELEASING PEPTIDE(31-98) AS A TUMOR-MARKER OF SMALL-CELL LUNG-CANCER - COMPARATIVE-EVALUATION WITH NEURON-SPECIFIC ENOLASE, British Journal of Cancer, 73(10), 1996, pp. 1227-1232
Risultati: 1-25 | 26-50